News &
Publications

Contacts

Lisa Bailey
Interim Director of Communications
Director of Social Networking
215-214-3954
215-872-5846 (cell phone)
Lisa.Bailey@fccc.edu

Diana Quattrone
Director of Media Relations
215-728-7784
215-815-7828 (cell phone)
Diana.Quattrone@fccc.edu

Communications Staff

 

News

Fox Chase Cancer Center Promotes Eric M. Horwitz, M.D., to Member in Department of Radiation Oncology

PHILADELPHIA (March 6, 2003) — Eric M. Horwitz, MD of Blue Bell, Pa. has been appointed a member of the division of medical science at Fox Chase Cancer Center. Fox Chase Cancer Center. Becoming a member, the equivalent of tenure at a university, requires a recommendation based on a review of the scientist's work by his or her peers.

Horwitz joined Fox Chase's department of radiation oncology in 1997. He is recognized nationally for his expertise in treating patients with prostate cancer and head and neck cancers.

"Dr. Horwitz is a very skillful clinician and innovative clinical investigator," radiation oncology chairman Alan Pollack, MD, PhD, said in announcing Horwitz' promotion.

At Fox Chase, Horwitz has developed advanced programs that include the temporary high-dose-rate (HDR) brachytherapy for prostate cancer, a treatment using temporary radiation implants. As a result, Fox Chase was the first in the Northeast United States to offer HDR implants to men with prostate cancer.

In addition, Horwitz integrated the use of an MRI treatment simulator into prostate cancer treatment planning both for permanent, low-dose prostate implants and external radiation therapy. Fox Chase was the first in the world to use the MRI in radiation treatment planning.

Before joining Fox Chase, Horwitz was chief resident in radiation oncology at William Beaumont Hospital in Royal Oak, Mich. He completed both his internship and residency there.

Horwitz received his M.D. from Albany College in New York after earning his undergraduate degree at the University of Pennsylvania in Philadelphia.


Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach.  For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Media inquiries only, please contact Diana Quattrone at 215-728-7784.

More 2003 News Releases »